Best Timmerman Report Podcasts (2025)

1
Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies 1:50:23

Play Pause

2h ago1:50:23

1:50:23

Jen Adair, professor and associate director of the Horae Gene Therapy Center at the University of Massachusetts Chan Medical School, on creating more affordable and accessible cell and gene therapies.By Timmerman Report

1
Summer Throwback: What is highest and best use and why does it matter? 5:05

3d ago5:05

5:05

Lisa and Amy round out their summer throwback series by revisiting an episode on highest and best use. Tune in on September 8th when Appraiser Talk returns with an exciting new series!By The Appraisal Foundation

1
Summer Throwback: Are there "typical" adjustments that are considered standard in the profession? 4:52

10d ago4:52

4:52

Lisa and Amy talk about adjustments on this week's summer throwback.By The Appraisal Foundation

1
Summer Throwback: What's the difference between an appraisal and the authentication of fine art? 5:07

17d ago5:07

5:07

Lisa and Amy are revisiting one of their personal property specific episodes in today's Summer Throwback.By The Appraisal Foundation

1
Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors 56:23

22d ago56:23

56:23

Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.By Timmerman Report

1
Summer Throwback: Can a borrower be an intended user of an appraisal report? 5:29

24d ago5:29

5:29

Building off last week's throwback, Lisa and Amy are sharing another past episode focusing on intended users.By The Appraisal Foundation

1
Summer Throwback: Who is the intended user? 6:58

1M ago6:58

6:58

Lisa and Amy continue their Summer Throwback series with an episode about intended users from the archives.By The Appraisal Foundation

1
Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science 1:01:18

1M ago1:01:18

1:01:18

Andy Rachleff and Yung Lie, board chair and CEO of Damon Runyon Cancer Research Foundation, on creative ways to support science amid budget cuts.By Timmerman Report

1
Summer Throwback: Why isn't the federal government in charge of writing these standards? 5:50

1M ago5:50

5:50

Lisa and Amy are sharing their favorite episodes of the podcast this summer. Next up, a closer look at the appraiser regulatory system.By The Appraisal Foundation

1
Summer Throwback: What is an appraiser valuing when they do an appraisal on my home? 8:25

2M ago8:25

8:25

Lisa and Amy continue their summer throwback series with a deep dive on this consumer question.By The Appraisal Foundation

1
Summer Throwback: When do I need to get an appraisal? 3:40

2M ago3:40

3:40

Lisa and Amy continue their Summer Throwback series to another early episode of the show answering a commonly asked consumer question.By The Appraisal Foundation

1
Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer 57:18

2M ago57:18

57:18

Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.By Timmerman Report

1
Summer Throwback: Our very first episode! 6:14

2M ago6:14

6:14

Appraiser Talk is on summer break, but while Lisa and Amy dream up new episodes, they're sharing some of their old favorite, starting with the very first episode of Appraiser Talk!By The Appraisal Foundation

1
Episode 199: "Do I also comply with USPAP automatically because I comply with standards set forth by the AICPA?" 6:10

2M ago6:10

6:10

Lisa and Amy discuss USPAP and AICPA standards.By The Appraisal Foundation

1
Episode 198: "Is a vacant 60-acre land parcel a residential or non-residential property?" 8:23

2M ago8:23

8:23

Lisa and Amy dive into an interesting question about appraising vacant land.By The Appraisal Foundation

1
Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA 1:10:45

3M ago1:10:45

1:10:45

John Rinn, professor at the University of Colorado and co-founder of Lincswitch Therapeutics, on exploring long non-coding RNA.By Timmerman Report

1
Episode 197: "How do appraisers comply with USPAP’s confidentiality rule?" 7:06

3M ago7:06

7:06

Lisa and Amy answer this question from an appraiser: If an appraiser completed an appraisal for one client, and then a new client asks for a 1004D update on that same property, how should the appraiser handle this while complying with USPAP’s confidentiality rule? Listen in to find out more!By The Appraisal Foundation

1
Episode 196: "Are only the appraisers signing the appraisal required to state whether they inspected the property?" 6:34

3M ago6:34

6:34

Lisa and Amy dive into a question about property inspection and report signatures.By The Appraisal Foundation

1
Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes 1:03:25

3M ago1:03:25

1:03:25

Marea Therapeutics CEO Josh Lehrer and CSO Ethan Weiss on a new angle of attack against cardiovascular disease and diabetes.By Timmerman Report

1
Episode 195: "Who controls the assignment conditions?" 6:28

3M ago6:28

6:28

Lisa and Amy do a deep dive on assignment conditions.By The Appraisal Foundation

1
Ep178: Peyton Greenside on ML-Guided Biologics Discovery 1:02:56

4M ago1:02:56

1:02:56

Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.By Timmerman Report

1
Episode 194: "What is the role of CAP?" 5:49

4M ago5:49

5:49

Amy and Lisa do a deep dive on The Appraisal Foundation's Course Approval Program.By The Appraisal Foundation

1
Episode 193: "How does USPAP define a special purpose property?" 6:14

4M ago6:14

6:14

Lisa fills Amy in on special purpose properties.By The Appraisal Foundation

1
Episode 192: "Is the appraiser required to sign the appraiser's independence certification?" 6:44

4M ago6:44

6:44

Lisa and Amy clear up confusion around what an appraiser certifies when they sign a report.By The Appraisal Foundation

1
Episode 191: "Why cant I use that appraisal report however I want?" 8:29

4M ago8:29

8:29

Lisa and Amy talk about appraisal reports and answer one of the most frequently asked questions appraisers get.By The Appraisal Foundation

1
Episode 190: "What is the difference between an assumption and an extraordinary assumption?" 5:51

5M ago5:51

5:51

Lisa and Amy are talking about assumptions this week, extraordinary and otherwise.By The Appraisal Foundation

1
Ep177: Kevin Parker on Finding Cancer Drug Targets 58:13

5M ago58:13

58:13

Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.By Timmerman Report

1
Episode 189: "Can an appraiser give an opinion 'off the cuff?'" 7:52

5M ago7:52

7:52

Lisa and Amy talk about "off the cuff" opinions and whether that's possible under USPAP.By The Appraisal Foundation

1
Episode 188: "What do appraisers wish real estate agents knew?" 5:48

5M ago5:48

5:48

Dan Bradley joins Amy and Lisa to talk about what appraisers wish real estate agents knew.By The Appraisal Foundation

1
Ep176: David Roblin on Building a TechBio Company 1:19:28

5M ago1:19:28

1:19:28

David Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.By Timmerman Report

1
Episode 187: "Is 5 months of supply really balanced?" 4:35

5M ago4:35

4:35

Lisa and Amy are joined by Ryan Lundquist to discuss supply and what balanced supply might be across markets.By The Appraisal Foundation

1
Episode 186: "What makes working in a rural setting unique as an appraiser? How do you handle things like livestock being present on a property in your appraisal?" 5:28

5M ago5:28

5:28

Special guest Mark Lewis joins Amy and Lisa to discuss his unique experiences as a rural appraiser.By The Appraisal Foundation

1
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies 1:10:46

6M ago1:10:46

1:10:46

Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.By Timmerman Report

1
Episode 185: "What is a subject property?" 9:11

6M ago9:11

9:11

Lisa and Amy do a deep dive on subject properties this week!By The Appraisal Foundation

1
Episode 184: "What does it mean that an appraisal is one type of typical market measure?" 7:01

6M ago7:01

7:01

Lisa and Amy talk about the idea of an appraisal being a type of typical market measure.By The Appraisal Foundation

1
Ep174: Najat Khan on the TechBio Movement 1:07:16

6M ago1:07:16

1:07:16

Najat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery.By Timmerman Report

1
Episode 183: "What is the difference between market value and appraised value?" 5:02

6M ago5:02

5:02

Lisa and Amy are back after a brief hiatus to discuss the difference between market value and appraised value!By The Appraisal Foundation

1
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders 57:56

7M ago57:56

57:56

Robert Blum, CEO of South San Francisco-based Cytokinetics, on building a fully integrated biopharma to treat muscle disorders.By Timmerman Report

1
Episode 182: "What is a 'zombie' condo and why would an investor or developer care?" 5:03

7M ago5:03

5:03

Lisa and Amy have a not so spooky episode to discuss "zombie" condos.By The Appraisal Foundation

1
Episode 181: "What is the project that inspired Farm Credit to become the Foundation's first contributor?" 3:40

7M ago3:40

3:40

Lisa and Amy are joined by special guest Tyler Mullins to discuss Farm Credit's exciting new role as the Foundation's first contributor and the project they are tackling together.By The Appraisal Foundation

1
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale 1:20:53

7M ago1:20:53

1:20:53

Mostafa Ronaghi, co-founder and executive board member of Cellanome, on developing technology to look at live cells and cellular interactions at scale.By Timmerman Report

1
Episode 180: "What is highest and best use, and why does it matter?" 5:05

8M ago5:05

5:05

Lisa and Amy kick off the new year with a discussion of highest and best use.By The Appraisal Foundation

1
Ep171: Ram Aiyar on RNA Editing Medicines 1:01:48

8M ago1:01:48

1:01:48

Ram Aiyar, CEO of Cambridge, Mass.-based Korro Bio, on RNA editing medicines.By Timmerman Report

1
Best of Appraiser Talk: "How does an appraiser deal with situations where market data is very mixed, unclear and contradictory?" 4:18

8M ago4:18

4:18

This week, Amy and Lisa are re-airing their most popular episode of 2024. Be sure to tune in!By The Appraisal Foundation

1
Ep170: David Schenkein on Investing in the Future of Biotech 59:52

8M ago59:52

59:52

David Schenkein, general partner at GV, on investing in the future of biotech.By Timmerman Report

1
Episode 178: "Can you tell us the history of the terms "purpose" and "function" in USPAP and how that relates to intended use?" 4:53

9M ago4:53

4:53

This week, Lisa and Amy are joined by Jack Young to talk about some important terms in USPAP!By The Appraisal Foundation

1
Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines 1:02:28

9M ago1:02:28

1:02:28

Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.By Timmerman Report

1
Episode 177: "What are the building blocks of an appraisal review?" 5:56

9M ago5:56

5:56

Special guest Hal Humphreys joins the show to talk to Amy and Lisa about appraisal reviews.By The Appraisal Foundation

1
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer 1:00:23

9M ago1:00:23

1:00:23

Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.By Timmerman Report

1
Episode 176: "What are the best practices, methods, and techniques for appraising religious facilities?" 3:40

9M ago3:40

3:40

Lisa and Amy are joined by special guest Bradley Carter to talk about appraising religious facilities.By The Appraisal Foundation